Antibody trial for advanced solid tumors
Part of Cancer clinical trials.
This trial tests an antibody treatment for people with stage IV cancer that has not responded to previous treatment. It aims to find a new option for patients with several types of advanced solid tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older with stage IV cancer of certain types (like breast, colon, lung, or melanoma).
- Your cancer must have gotten worse after at least one standard treatment, or you have chosen not to have more standard therapy.
- You need to have tumor tissue available for genetic testing, or be willing to have a biopsy to get it.
- Your tumor must be measurable on scans.
- You must have a Karnofsky score of 60 or higher, meaning you can care for most daily needs.
- Your blood counts, kidney, and liver function must be within certain limits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new type of immunotherapy for people with advanced cancer that has not responded to standard treatments. It aims to see if this personalized approach is safe and effective.
This early-stage study tests an investigational drug (MHB088C) in adults with advanced or metastatic solid cancers that have gotten worse or can’t be treated with standard options. It aims to see if the drug is safe and can shrink tumors or control the cancer.
This trial tests an experimental drug called MHB046C for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if it can shrink tumors or slow their growth.
This Phase 1 trial tests a new drug called IUAb190708 designed to help your immune system fight advanced or recurrent solid cancers. The study will evaluate its safety, how your body handles it, and whether it works against your tumor.
This trial tests an experimental drug for people with advanced solid tumors, including small cell lung cancer, that have stopped responding to standard treatments. The goal is to find out if the drug is safe and effective.
This trial tests a new drug called BT02 for people with advanced solid tumors who have not had any cancer treatment before. It aims to see if BT02 is safe and how well it works.
Hear when a new Soft Tissue Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.